Observational × Pancreatic Neoplasms × Dermatologic × Clear all TraveraRTGx
Completed
72 enrolled
DP-04
Recruiting
100 enrolled
Pancreas Registry and High Risk Registry
Recruiting
1,368 enrolled
SJFAMILY
Recruiting
1,500 enrolled
iCaRe2
Recruiting
999,999 enrolled
Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
Active not recruiting
6,000 enrolled
SCORE
Recruiting
9,600 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
Enrolling by invitation
1,200 enrolled
DELFI-L101
Completed
2,992 enrolled
PARTNER
Recruiting
6,250 enrolled
Tempus Priority Study: A Pan-tumor Observational Study
Active not recruiting
1,000 enrolled
PREFER
Completed
1,429 enrolled
MOHCCN-O
Recruiting
500 enrolled
ROOT
Completed
167 enrolled
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Completed
17,667 enrolled
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
Terminated
20 enrolled
POPCORN
Recruiting
782 enrolled
Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study
Unknown
500 enrolled
Collecting Solid Tumor Tissue to Identify New Treatments
Completed
133 enrolled
TCOG
Completed
3 enrolled
Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy
Terminated
98 enrolled
HSP70CTC
Unknown
120 enrolled
PIONEER
Unknown
1,000 enrolled
E-MOSAIC Electronic Tool to Monitor Symptoms
Completed
264 enrolled
N1
Terminated
23 enrolled
Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial
Terminated
241 enrolled
Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers
Terminated
40 enrolled
Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants
Completed
54 enrolled
Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.
Completed
803 enrolled
B-Receptor Signaling in Cardiomyopathy
Completed
99 enrolled
Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer
Terminated
180 enrolled
Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
Unknown
14,000 enrolled